A new single-use device reduces surgical site infections, improves recovery, and lowers costs after Cesarean (C-section) ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...